U.S. Transportation Stock News

NYSE:ADC
NYSE:ADCRetail REITs

Agree Realty (ADC) Could Be 13% Undervalued On Its Monthly Dividend Update

Agree Realty (ADC) has declared a monthly dividend of US$0.2670 per share, payable on September 15, 2026. The ex-dividend and record dates are both set for August 31, 2026. See our latest analysis for Agree Realty. Agree Realty's share price has eased in recent weeks, with a 1-month share price return of down 7.9% and a year to date share price return of 2.44%. The 1-year total shareholder return of 5.39% and 3-year total shareholder return of 35.94% point to a stronger longer term record. If...
NYSE:LPG
NYSE:LPGOil and Gas

DorianG (LPG) Is Up 7.9% After Recycling Fleet Capital Into VLGC Growth - What's Changed

Dorian LPG recently pushed its ship sales beyond US$340 million while continuing to expand its very large gas carrier (VLGC) fleet, reinforcing its role in global liquefied petroleum gas transportation. This combination of asset sales and fleet growth highlights a capital recycling approach that may influence how investors view the company’s operational and capital allocation priorities. We’ll now examine how Dorian LPG’s push to grow and refresh its VLGC fleet could reshape the existing...
NasdaqGS:DBX
NasdaqGS:DBXSoftware

Should Dropbox’s Flat 2026 Revenue Outlook Amid Margin Gains Require Action From Dropbox (DBX) Investors?

Earlier this week, Zacks Equity Research named Dropbox its “Bear of the Day,” citing slowing momentum and flat revenue growth guidance for 2026 despite a solid second-quarter showing and rising paying users. The contrast between improved operating-margin and free-cash-flow outlooks and muted revenue expectations has sharpened concerns about the company’s longer-term growth profile. We’ll now examine how Dropbox’s expectation of flat 2026 revenue growth could influence its investment...
NYSE:DAC
NYSE:DACShipping

Danaos (DAC) Stock Still Looks Below Fair Value Despite A 152% Run

Danaos stock has delivered very strong returns over the past few years, yet at around US$149.75 per share the company still screens as undervalued on both an intrinsic value estimate using a Discounted Cash Flow (DCF) approach and on market multiples. For investors, that combination of a big share price gain and a valuation signal that still leans cheap is worth a closer look. Over the past 3 years, Danaos has returned 152.3%, which puts the recent share price strength front and center in...
NYSE:BSX
NYSE:BSXMedical Equipment

Should Boston Scientific’s Shift Toward Capital Spending and External Innovation Require Action From (BSX) Investors?

Boston Scientific recently shifted its capital budget above its research budget for the first time in fifteen years, while planning seven new product launches and pursuing run-rate savings from cost programs to restore growth amid competitive pressure in Electrophysiology and softer WATCHMAN revenues. An interesting twist is that two of the seven growth-driving launches are coming from outside Boston Scientific’s own labs, underscoring a greater reliance on external innovation alongside...
NYSE:GNW
NYSE:GNWInsurance

Why Genworth Financial (GNW) Is Getting Attention Today

Genworth Financial (GNW) has put leadership back in familiar hands, with Thomas J. McInerney set to return from a leave of absence and resume the roles of President and Chief Executive Officer on September 2, 2026. See our latest analysis for Genworth Financial. Genworth Financial’s recent executive news comes after a year where the stock shows mixed momentum, with a 10.14% year to date share price return but a 165.59% five year total shareholder return that reflects a much stronger long term...
NYSE:BKE
NYSE:BKESpecialty Retail

Is Buckle (BKE) A Bargain On Q2 Results Or Already Fully Priced?

Buckle (BKE) just reported second quarter results, with sales of US$319.82 million and net income of US$44.41 million, while comparable store and online sales both moved higher versus a year ago. See our latest analysis for Buckle. Buckle shares have been choppy this year, with the year to date share price return down 18.66% despite a 2.74% gain on the day of the results. The 5 year total shareholder return of 82.51% reflects a much stronger longer term outcome. If Buckle’s update has you...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Dollar Tree (DLTR) Stock Looks Cheap On Cash Flow But Less Cheap On Earnings

Dollar Tree stock has posted a 44.7% return over the past five years, while both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiple checks currently point to the shares trading at a discount to those fundamentals. A 44.7% gain over five years suggests Dollar Tree has already rewarded patient shareholders, yet current pricing still screens as undervalued on key valuation tools. For Dollar Tree, the long term investment case can hinge on how consistently it...
NasdaqGS:HUT
NasdaqGS:HUTSoftware

What Does Hut 8 (HUT) Proposed $2.35 Million Settlement Mean For Investors?

Hut 8 (NasdaqGS:HUT) is involved in a proposed US class action settlement of approximately US$2.35 million covering certain purchasers of its securities. A US District Court has approved the announcement of the proposed settlement and set out a court hearing process for final approval. The settlement framework outlines rights and deadlines for affected investors who bought Hut 8 securities during the specified period. The case highlights legal, governance, and disclosure considerations that...
NYSE:KNX
NYSE:KNXTransportation

Knight Swift Transportation Holdings (KNX) Beat Second Quarter Estimates, Is The Upside Already Priced In?

Why Knight-Swift Transportation Holdings Stock Is Back in Focus Knight-Swift Transportation Holdings (KNX) is drawing fresh attention after second-quarter 2026 adjusted earnings and revenue came in above analyst expectations, supported by stronger pricing, better network efficiency, and gains in truckload and intermodal operations. See our latest analysis for Knight-Swift Transportation Holdings. The earnings beat and upbeat third quarter outlook come after a mixed stretch for Knight-Swift...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Tempus AI (TEM) Stock Could Be 33% Undervalued Following Cancer Vaccine News

Tempus AI stock has rallied strongly in the past month, yet its valuation checks are pulling in different directions, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) pointing to upside while market multiples lean expensive. Tempus AI has returned 54.8% over the past month, which puts extra focus on whether recent optimism is already reflected in the share price. The surge in interest following positive cancer vaccine trial news and the planned US$1.5b Personalis...
NYSE:GEO
NYSE:GEOCommercial Services

GEO Group (GEO) Could Be 18% Undervalued Following Colorado Injunction Relief

Regulatory injunction reshapes near term backdrop for GEO Group stock A federal judge blocked key sections of a Colorado law affecting GEO Group (GEO) and its Aurora ICE detention center, easing some regulatory pressure and allowing existing federal contract terms to continue unchanged until October 15, 2026. See our latest analysis for GEO Group. The latest court ruling comes as GEO Group's share price has risen 3.1% in the last day and 39.1% over 90 days, with a year-to-date share price...
NasdaqGS:CBRS
NasdaqGS:CBRSSemiconductor

3 AI Stocks Powering The Next Wave Of Cloud And Automation

Services activity in the United States is currently the strongest it has been in 20 months, which highlights how much of daily life is shifting toward digital and data driven experiences. That dependence on software and cloud infrastructure keeps artificial intelligence and ChatGPT linked tools in sharp focus for investors hunting for growth themes. This article walks through 3 AI stocks from the screener that help turn that theme into a practical watchlist. The three stocks below are just a...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

LeMaitre Vascular (LMAT) Could Be 26% Undervalued On Mixed Valuation Views

LeMaitre Vascular (LMAT) has drawn investor attention after its share price declined about 17% over the past month and about 16% over the past 3 months, prompting fresh questions about valuation and fundamentals. See our latest analysis for LeMaitre Vascular. At a share price of US$81.86, LeMaitre Vascular has seen short term momentum fade, with the 30 day share price return down 17.15% and the 1 year total shareholder return down 17.58%, even though the 3 and 5 year total shareholder returns...
NYSE:RPM
NYSE:RPMChemicals

Is RPM’s Upbeat FY2027 Outlook Reshaping the Pricing Power and Efficiency Story for RPM (RPM)?

Earlier in fiscal 2026, RPM International reported a strong fourth-quarter, with adjusted earnings and net sales both topping estimates and rising from the prior year. Management also issued guidance for fiscal 2027 calling for mid-single-digit sales growth and higher adjusted EBITDA, signaling confidence across all segments. Next, we’ll examine how RPM’s upbeat fiscal 2027 sales and EBITDA outlook influences the existing investment narrative around pricing power and efficiency. The future...
NYSE:BLK
NYSE:BLKCapital Markets

Should BlackRock’s (BLK) Union-Backed AI Infrastructure Push Reshape Its Long-Term Investment Narrative?

Earlier this month, North America's Building Trades Unions, BlackRock, and the AI Infrastructure Partnership signed a Memorandum of Understanding to support US AI and energy infrastructure buildout, expand workforce training, and improve project execution at data centers and related facilities. This agreement is interesting because it directly links BlackRock’s AI and energy infrastructure ambitions with a structured pipeline of skilled labor and apprenticeship programs, potentially...
NYSE:P
NYSE:PTech

Everpure (P) Named A Gartner Leader For The Second Straight Year

Everpure (NYSE:P) has been recognized as a Leader in the 2026 Gartner Magic Quadrant for Enterprise Storage Platforms. This is the second consecutive year Everpure has appeared in the Leader quadrant. The recognition highlights Gartner's assessment of Everpure's execution in enterprise storage and completeness of vision. Everpure is one of several companies tied to the build out of modern storage and AI infrastructure. It can be useful to compare this story with a wider group of stocks...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Ecopipam Priority Review Could Be A Game Changer For Teva Pharmaceutical Industries (TEVA)

In August 2026, Teva Pharmaceuticals announced that the FDA accepted and granted Priority Review to its New Drug Application for ecopipam, a first-in-class D1 receptor antagonist for pediatric Tourette syndrome, supported by positive Phase 2b and Phase 3 data and backed by Orphan Drug designation. If approved, ecopipam could become the first new pediatric Tourette syndrome treatment in more than a decade and introduce a novel mechanism of action in this condition for the first time in over...
NasdaqGS:CASH
NasdaqGS:CASHBanks

Pathward Financial (CASH) Stock Trades Cheap On A 74% Three Year Run

Pathward Financial stock has delivered a strong 73.9% return over the past three years, yet its current valuation checks still suggest the shares lean cheap rather than fully priced. Over the last three years, Pathward Financial has returned 73.9%, which puts more focus on whether the current share price still offers a margin of value support. The key driver for the valuation case is how consistently Pathward Financial can convert its business model into earnings and cash flow, while the...
NasdaqGS:BCRX
NasdaqGS:BCRXBiotechs

BioCryst Pharmaceuticals (BCRX), What Is Behind The Fresh Attention Now?

BioCryst Pharmaceuticals (BCRX) has drawn fresh attention after recent trading left the stock around $9.55, with returns that differ sharply across timeframes. Investors are now weighing this performance against the company’s rare disease drug portfolio. See our latest analysis for BioCryst Pharmaceuticals. Over the past year, BioCryst Pharmaceuticals has seen a mixed picture, with the share price at $9.55 supported by a 27.33% year to date share price return, but a 5 year total shareholder...
NYSE:PWR
NYSE:PWRConstruction

Quanta Services (PWR) Stock Looks Stretched On Cash Flow And Earnings

Quanta Services stock has delivered a very large 5 year return, yet the latest valuation work suggests the current US$639.34 share price is trading at a premium to its intrinsic value estimate. Quanta Services has returned roughly 5.2x an initial investment over 5 years, which puts extra focus on whether the current price still offers a comfortable margin of safety. The business can benefit if investors continue to expect solid long term cash generation from its infrastructure projects...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Should Ardelyx’s Cut IBSRELA Guidance and CCO Exit Require Action From Ardelyx (ARDX) Investors?

Ardelyx recently cut its full-year 2026 IBSRELA revenue guidance to US$350–US$370 million, withdrew a long-term XPHOZAH sales target, filed a US$36 million shelf registration for an ESOP-related common stock offering, and announced the past resignation of Chief Commercial Officer Eric Foster effective August 28, 2026. Together, the lowered guidance, withdrawal of a key revenue goal, and leadership change underscore how payer hurdles are pressuring Ardelyx’s commercial execution and long-term...
NasdaqGM:FUTU
NasdaqGM:FUTUCapital Markets

3 Asset Managers Investors May Watch As Cash And Money Market Demand Grows

With the Buffett Indicator hovering around 238% and Warren Buffett himself content to sit on a growing pile of cash and T bills, many investors are wondering whether more of their portfolio should also lean toward short duration assets. Elevated valuations and the war in Iran have sharpened interest in cash style exposure. This article unpacks that story and walks through 3 stocks exposed to this theme. The stocks covered below are just a starting sample of this short duration cash theme, and...
NasdaqGS:STLD
NasdaqGS:STLDMetals and Mining

Deere Stock And 2 Industrial Picks Tied To US Onshoring Shift

With the U.S. slapping 50% tariffs on selected Canadian imports and Canada firing back with dollar for dollar measures, cross border supply chains are under fresh pressure. That kind of shock can hurt some stocks and create room for others that are tied more closely to U.S. manufacturing and onshoring. This article walks through 3 stocks exposed to this news and how the shifting trade backdrop could matter for their stories. The stocks covered below are just a starting sample. The full screen...